
|Articles|June 15, 2004
Topical cyclosporine can handle more than just dry eye disease
Any T cell-mediated disease found to benefit from this therapy without affecting other inflammatory pathways
Advertisement
Newsletter
Stay at the forefront of cutting-edge science with CGT—your direct line to expert insights, breakthrough data, and real-time coverage of the latest advancements in cell and gene therapy.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CGTlive®
1
FasTCAR Manufactured BCMAxCD19 CAR T-cell Therapy Shows Promise for Multiple Myeloma
2
Crawford Strunk, MD, on the Importance of Palliative Care in Sickle Cell Disease
3
Crawford Strunk, MD, on Integrating Gene Therapy into Clinical Care for Sickle Cell Disease
4
The Importance of Palliative Care in Sickle Cell Disease
5

















































